AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Quantitative Assessment of Signal Loss in Cardiotocography Using External Recording

Recruitingn/aAges 18 Years - 45 YearsFemaleUniversity Hospital, Strasbourg, France
💬

In plain words

What the trial is, and whether it could suit you

Signal loss in cardiotocography (CTG) recordings is numerous and frequent, whether due to artifacts in signal acquisition or confusion over inadvertent maternal heart rate recording, with various negative consequences for neonatal morbidity and unnecessary obstetric interventions. Data on this issue are 10 to 15 years old. CTG remains the primary method for assessing fetal well-being during labor, almost systematically.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * Adult female (≥ 18 years old) * Patient treated at a hospital between February 1, 2024 and February 28, 2024 * Having undergone cardiotocography in the labor and delivery room * Gestational age at delivery \>36 weeks Exclusion Criteria: * Patient who has expressed opposition to the use of medical record data * Patient without CTG * Gestational age at delivery \<36 weeks
💊

What it tests

  • Not listed
📍

Where

1 site
Service de Gynécologie-Obstétrique CMCO - CHU de Strasbourg - France
Strasbourg, France
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy